$FOLD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AMICUS THERAPEUTICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in AMICUS THERAPEUTICS, INC.. Get notifications about new insider transactions in AMICUS THERAPEUTICS, INC. for free.
Page: < prev 1 ... 8 9 10 11 12 13 14 15 16 ... 28 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 25 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.52 | 108 | 1,460 | 68,372 | 68.5 K to 68.4 K (-0.16 %) |
Aug 25 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.52 | 2,892 | 39,109 | 1,830,976 | 1.8 M to 1.8 M (-0.16 %) |
Aug 25 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.57 | 108 | 1,466 | 68,480 | 68.6 K to 68.5 K (-0.16 %) |
Aug 25 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.57 | 2,892 | 39,253 | 1,833,868 | 1.8 M to 1.8 M (-0.16 %) |
Aug 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.72 | 108 | 1,482 | 68,588 | 68.7 K to 68.6 K (-0.16 %) |
Aug 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.72 | 2,892 | 39,678 | 1,836,760 | 1.8 M to 1.8 M (-0.16 %) |
Aug 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.56 | 108 | 1,464 | 68,696 | 68.8 K to 68.7 K (-0.16 %) |
Aug 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.56 | 2,892 | 39,207 | 1,839,652 | 1.8 M to 1.8 M (-0.16 %) |
Aug 21 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 13.54 | 2,000 | 27,070 | 46,449 | 48.4 K to 46.4 K (-4.13 %) |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 14.50 | 700 | 10,149 | 48,449 | 49.1 K to 48.4 K (-1.42 %) |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 13.71 | 3,800 | 52,094 | 49,149 | 52.9 K to 49.1 K (-7.18 %) |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 16.04 | 800 | 12,834 | 52,949 | 53.7 K to 52.9 K (-1.49 %) |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 15.02 | 2,700 | 40,554 | 53,749 | 56.4 K to 53.7 K (-4.78 %) |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Option Exercise | M | 0.64 | 1,401 | 893 | 22,237 | |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 15.11 | 1,401 | 21,164 | 152 | 1.6 K to 152 (-90.21 %) |
Aug 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Buy | M | 0.64 | 1,401 | 893 | 1,553 | 152 to 1.6 K (+921.71 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.82 | 45 | 667 | 68,804 | 68.8 K to 68.8 K (-0.07 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.45 | 63 | 973 | 68,849 | 68.9 K to 68.8 K (-0.09 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.84 | 1,255 | 18,618 | 1,842,544 | 1.8 M to 1.8 M (-0.07 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.46 | 1,637 | 25,303 | 1,843,799 | 1.8 M to 1.8 M (-0.09 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.46 | 108 | 1,778 | 68,912 | 69 K to 68.9 K (-0.16 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.46 | 2,892 | 47,605 | 1,845,436 | 1.8 M to 1.8 M (-0.16 %) |
Aug 19 2008 | FOLD | AMICUS THERAPEUTIC ... | SBLENDORIO GLENN | Director | Sell | S | 16.74 | 1,400 | 23,439 | 12,933 | 14.3 K to 12.9 K (-9.77 %) |
Aug 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Weinhoff Gregory M | Director | Sell | S | 17.00 | 3,156 | 53,652 | 129,943 | 133.1 K to 129.9 K (-2.37 %) |
Aug 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Weinhoff Gregory M | Director | Sell | S | 17.00 | 46,844 | 796,348 | 1,928,612 | 2 M to 1.9 M (-2.37 %) |
Aug 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.03 | 362 | 6,166 | 69,020 | 69.4 K to 69 K (-0.52 %) |
Aug 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.03 | 9,704 | 165,279 | 1,848,328 | 1.9 M to 1.8 M (-0.52 %) |
Aug 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.57 | 205 | 3,602 | 69,382 | 69.6 K to 69.4 K (-0.29 %) |
Aug 15 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.57 | 5,495 | 96,553 | 1,858,032 | 1.9 M to 1.9 M (-0.29 %) |
Aug 14 2008 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | Sr. VP, HR & Lead.D ... | Sell | S | 18.00 | 5 | 90 | 12,582 | 12.6 K to 12.6 K (-0.04 %) |
Aug 14 2008 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | Sr. VP, HR & Lead.D ... | Sell | S | 18.00 | 208 | 3,744 | 12,587 | 12.8 K to 12.6 K (-1.63 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.65 | 120 | 1,998 | 69,587 | 69.7 K to 69.6 K (-0.17 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.28 | 154 | 2,661 | 69,707 | 69.9 K to 69.7 K (-0.22 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.66 | 3,280 | 54,632 | 1,863,527 | 1.9 M to 1.9 M (-0.18 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.29 | 4,066 | 70,281 | 1,866,807 | 1.9 M to 1.9 M (-0.22 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.26 | 108 | 1,756 | 69,861 | 70 K to 69.9 K (-0.15 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.37 | 18 | 313 | 69,969 | 70 K to 70 K (-0.03 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.26 | 2,892 | 47,021 | 1,870,873 | 1.9 M to 1.9 M (-0.15 %) |
Aug 13 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 17.38 | 482 | 8,375 | 1,873,765 | 1.9 M to 1.9 M (-0.03 %) |
Aug 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.70 | 108 | 1,803 | 69,987 | 70.1 K to 70 K (-0.15 %) |
Aug 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.70 | 2,892 | 48,288 | 1,874,247 | 1.9 M to 1.9 M (-0.15 %) |
Aug 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.58 | 151 | 2,504 | 70,095 | 70.2 K to 70.1 K (-0.21 %) |
Aug 11 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.58 | 4,049 | 67,132 | 1,877,139 | 1.9 M to 1.9 M (-0.22 %) |
Aug 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Schaeffer Orlov S Nicole | Sr.VP, HR & Leaders ... | Option Exercise | A | 16.71 | 10,000 | 167,100 | 10,000 | |
Aug 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.60 | 109 | 1,701 | 70,246 | 70.4 K to 70.2 K (-0.15 %) |
Aug 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.77 | 67 | 1,123 | 70,355 | 70.4 K to 70.4 K (-0.10 %) |
Aug 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.60 | 2,891 | 45,108 | 1,881,188 | 1.9 M to 1.9 M (-0.15 %) |
Aug 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 16.75 | 1,812 | 30,353 | 1,884,079 | 1.9 M to 1.9 M (-0.10 %) |
Aug 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.55 | 108 | 1,680 | 70,422 | 70.5 K to 70.4 K (-0.15 %) |
Aug 07 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.55 | 2,892 | 44,982 | 1,885,891 | 1.9 M to 1.9 M (-0.15 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 15.61 | 220 | 3,434 | 35,155 | 35.4 K to 35.2 K (-0.62 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.22 | 3,000 | 45,648 | 20,200 | 23.2 K to 20.2 K (-12.93 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.27 | 3,200 | 48,858 | 33,133 | 36.3 K to 33.1 K (-8.81 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.43 | 2,000 | 30,858 | 23,200 | 25.2 K to 23.2 K (-7.94 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President & CEO | Sell | S | 15.42 | 1,800 | 27,747 | 36,333 | 38.1 K to 36.3 K (-4.72 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.23 | 162 | 2,468 | 70,530 | 70.7 K to 70.5 K (-0.23 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.23 | 4,338 | 66,085 | 1,888,783 | 1.9 M to 1.9 M (-0.23 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.45 | 133 | 2,055 | 70,692 | 70.8 K to 70.7 K (-0.19 %) |
Aug 05 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.45 | 3,567 | 55,114 | 1,893,121 | 1.9 M to 1.9 M (-0.19 %) |
Aug 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.47 | 360 | 5,567 | 70,825 | 71.2 K to 70.8 K (-0.51 %) |
Aug 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15,465.00 | 9,640 | 149,082,600 | 1,896,688 | 1.9 M to 1.9 M (-0.51 %) |
Aug 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.19 | 169 | 2,566 | 71,185 | 71.4 K to 71.2 K (-0.24 %) |
Aug 01 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.19 | 4,531 | 68,803 | 1,906,328 | 1.9 M to 1.9 M (-0.24 %) |
Jul 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.30 | 130 | 1,989 | 71,354 | 71.5 K to 71.4 K (-0.18 %) |
Jul 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.30 | 3,470 | 53,098 | 1,910,859 | 1.9 M to 1.9 M (-0.18 %) |
Jul 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.23 | 324 | 4,933 | 71,484 | 71.8 K to 71.5 K (-0.45 %) |
Jul 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.23 | 8,676 | 132,092 | 1,914,329 | 1.9 M to 1.9 M (-0.45 %) |
Jul 30 2008 | FOLD | AMICUS THERAPEUTIC ... | Palling David | Senior VP, Drug Dev ... | Sell | S | 15.08 | 2,500 | 37,693 | 59,616 | 62.1 K to 59.6 K (-4.02 %) |
Jul 28 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.43 | 83 | 1,281 | 71,808 | 71.9 K to 71.8 K (-0.12 %) |
Jul 28 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.43 | 2,217 | 34,213 | 1,923,005 | 1.9 M to 1.9 M (-0.12 %) |
Jul 28 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.24 | 204 | 3,108 | 71,891 | 72.1 K to 71.9 K (-0.28 %) |
Jul 28 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.24 | 5,457 | 83,137 | 1,925,222 | 1.9 M to 1.9 M (-0.28 %) |
Jul 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.00 | 66 | 990 | 72,095 | 72.2 K to 72.1 K (-0.09 %) |
Jul 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.00 | 1,768 | 26,516 | 1,930,679 | 1.9 M to 1.9 M (-0.09 %) |
Jul 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.01 | 309 | 4,637 | 72,161 | 72.5 K to 72.2 K (-0.43 %) |
Jul 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 15.01 | 8,280 | 124,241 | 1,932,447 | 1.9 M to 1.9 M (-0.43 %) |
Jul 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Option Exercise | M | 0.64 | 15,000 | 9,563 | 23,638 | |
Jul 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 15.00 | 15,000 | 225,000 | 152 | 15.2 K to 152 (-99.00 %) |
Jul 23 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Buy | M | 0.64 | 15,000 | 9,563 | 15,152 | 152 to 15.2 K (+9,868.42 %) |
Jul 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.38 | 58 | 776 | 73,118 | 73.2 K to 73.1 K (-0.08 %) |
Jul 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.38 | 1,542 | 20,626 | 1,958,079 | 2 M to 2 M (-0.08 %) |
Jul 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.16 | 68 | 895 | 73,176 | 73.2 K to 73.2 K (-0.09 %) |
Jul 18 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.16 | 1,832 | 24,113 | 1,959,621 | 2 M to 2 M (-0.09 %) |
Jul 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.47 | 274 | 3,965 | 72,470 | 72.7 K to 72.5 K (-0.38 %) |
Jul 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 14.47 | 7,326 | 106,007 | 1,940,727 | 1.9 M to 1.9 M (-0.38 %) |
Jul 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.86 | 374 | 5,183 | 72,744 | 73.1 K to 72.7 K (-0.51 %) |
Jul 22 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 13.86 | 10,026 | 138,940 | 1,948,053 | 2 M to 1.9 M (-0.51 %) |
Jul 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Option Exercise | M | 0.64 | 15,000 | 9,563 | 38,638 | |
Jul 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Sell | S | 13.00 | 15,000 | 195,000 | 152 | 15.2 K to 152 (-99.00 %) |
Jul 17 2008 | FOLD | AMICUS THERAPEUTIC ... | Licholai Gregory P | VP, Medical Affairs | Buy | M | 0.64 | 15,000 | 9,563 | 15,152 | 152 to 15.2 K (+9,868.42 %) |
Jul 16 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.90 | 202 | 2,605 | 73,244 | 73.4 K to 73.2 K (-0.28 %) |
Jul 16 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.90 | 5,398 | 69,607 | 1,961,453 | 2 M to 2 M (-0.27 %) |
Jul 16 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.61 | 57 | 719 | 73,446 | 73.5 K to 73.4 K (-0.08 %) |
Jul 16 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.61 | 1,543 | 19,453 | 1,966,851 | 2 M to 2 M (-0.08 %) |
Jul 16 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.55 | 320 | 4,016 | 73,503 | 73.8 K to 73.5 K (-0.43 %) |
Jul 16 2008 | FOLD | AMICUS THERAPEUTIC ... | Bloch Stephen M | Director | Sell | S | 12.55 | 8,573 | 107,591 | 1,968,394 | 2 M to 2 M (-0.43 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.24 | 300 | 3,372 | 25,200 | 25.5 K to 25.2 K (-1.18 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.22 | 400 | 4,488 | 25,500 | 25.9 K to 25.5 K (-1.54 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.16 | 135 | 1,507 | 25,900 | 26 K to 25.9 K (-0.52 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.15 | 65 | 725 | 26,035 | 26.1 K to 26 K (-0.25 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.70 | 100 | 1,070 | 26,100 | 26.2 K to 26.1 K (-0.38 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.26 | 200 | 2,252 | 38,133 | 38.3 K to 38.1 K (-0.52 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.24 | 208 | 2,338 | 38,333 | 38.5 K to 38.3 K (-0.54 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.23 | 100 | 1,123 | 38,541 | 38.6 K to 38.5 K (-0.26 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.22 | 300 | 3,366 | 38,641 | 38.9 K to 38.6 K (-0.77 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.19 | 92 | 1,029 | 38,941 | 39 K to 38.9 K (-0.24 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 200 | 2,150 | 39,033 | 39.2 K to 39 K (-0.51 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.69 | 100 | 1,069 | 39,233 | 39.3 K to 39.2 K (-0.25 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.03 | 200 | 2,206 | 26,200 | 26.4 K to 26.2 K (-0.76 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.89 | 100 | 1,089 | 26,400 | 26.5 K to 26.4 K (-0.38 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 300 | 3,225 | 26,500 | 26.8 K to 26.5 K (-1.12 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.73 | 100 | 1,073 | 26,800 | 26.9 K to 26.8 K (-0.37 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.03 | 200 | 2,206 | 39,333 | 39.5 K to 39.3 K (-0.51 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 400 | 4,300 | 39,533 | 39.9 K to 39.5 K (-1.00 %) |
Jul 08 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.73 | 200 | 2,146 | 39,933 | 40.1 K to 39.9 K (-0.50 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.11 | 700 | 7,777 | 26,900 | 27.6 K to 26.9 K (-2.54 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.09 | 209 | 2,318 | 27,600 | 27.8 K to 27.6 K (-0.75 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.08 | 200 | 2,216 | 27,809 | 28 K to 27.8 K (-0.71 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.06 | 100 | 1,106 | 28,009 | 28.1 K to 28 K (-0.36 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.04 | 91 | 1,005 | 28,109 | 28.2 K to 28.1 K (-0.32 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.92 | 100 | 1,092 | 28,200 | 28.3 K to 28.2 K (-0.35 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.79 | 23 | 248 | 28,300 | 28.3 K to 28.3 K (-0.08 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.78 | 600 | 6,468 | 28,323 | 28.9 K to 28.3 K (-2.07 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.76 | 100 | 1,076 | 28,923 | 29 K to 28.9 K (-0.34 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.75 | 100 | 1,075 | 29,023 | 29.1 K to 29 K (-0.34 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.73 | 300 | 3,219 | 29,123 | 29.4 K to 29.1 K (-1.02 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.72 | 477 | 5,113 | 29,423 | 29.9 K to 29.4 K (-1.60 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.63 | 100 | 1,063 | 29,900 | 30 K to 29.9 K (-0.33 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.13 | 200 | 2,226 | 40,133 | 40.3 K to 40.1 K (-0.50 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.11 | 600 | 6,666 | 40,333 | 40.9 K to 40.3 K (-1.47 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.08 | 200 | 2,216 | 40,933 | 41.1 K to 40.9 K (-0.49 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.06 | 400 | 4,424 | 41,133 | 41.5 K to 41.1 K (-0.96 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 11.00 | 100 | 1,100 | 41,533 | 41.6 K to 41.5 K (-0.24 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.92 | 100 | 1,092 | 41,633 | 41.7 K to 41.6 K (-0.24 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.76 | 500 | 5,380 | 41,733 | 42.2 K to 41.7 K (-1.18 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.72 | 800 | 8,576 | 42,233 | 43 K to 42.2 K (-1.86 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.70 | 200 | 2,140 | 43,033 | 43.2 K to 43 K (-0.46 %) |
Jul 03 2008 | FOLD | AMICUS THERAPEUTIC ... | Crowley John F | President and CEO | Sell | S | 10.62 | 100 | 1,062 | 43,233 | 43.3 K to 43.2 K (-0.23 %) |
Jul 02 2008 | FOLD | AMICUS THERAPEUTIC ... | Dentzer James E | Chief Financial Off ... | Payment of Exercise | F | 10.81 | 220 | 2,378 | 35,375 | 35.6 K to 35.4 K (-0.62 %) |
Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.54 | 400 | 4,616 | 58,549 | 58.9 K to 58.5 K (-0.68 %) |
Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.50 | 200 | 2,300 | 58,949 | 59.1 K to 58.9 K (-0.34 %) |
Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.35 | 400 | 4,540 | 59,149 | 59.5 K to 59.1 K (-0.67 %) |
Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.26 | 123 | 1,385 | 59,549 | 59.7 K to 59.5 K (-0.21 %) |
Jun 24 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.25 | 277 | 3,116 | 59,672 | 59.9 K to 59.7 K (-0.46 %) |
Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.11 | 14 | 156 | 59,949 | 60 K to 59.9 K (-0.02 %) |
Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.03 | 300 | 3,309 | 59,963 | 60.3 K to 60 K (-0.50 %) |
Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.02 | 86 | 948 | 60,263 | 60.3 K to 60.3 K (-0.14 %) |
Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.12 | 100 | 1,112 | 60,349 | 60.4 K to 60.3 K (-0.17 %) |
Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.02 | 200 | 2,204 | 60,449 | 60.6 K to 60.4 K (-0.33 %) |
Jun 20 2008 | FOLD | AMICUS THERAPEUTIC ... | Patterson Matthew R | Chief Operating Off ... | Sell | S | 11.01 | 200 | 2,202 | 60,649 | 60.8 K to 60.6 K (-0.33 %) |